Importance Carotid artery stenting has been limited to use in patients with high surgical risk;
outcomes in patients with standard surgical risk are not well known. Objective To compare …

Importance Several trials have observed higher rates of perioperative stroke following
transfemoral carotid artery stenting compared with carotid endarterectomy. Transcarotid …

Background Transcarotid artery revascularization (TCAR) was approved by the Food and
Drug Administration in 2015 for patients with carotid artery stenosis. However, no …

Importance A transcarotid artery revascularization (TCAR) device was approved by the US
Food and Drug Administration in 2015 for carotid revascularization in patients at high risk for …

METHODS: The National Inpatient Database was used for years 2015 to 2019. A
multivariate logistic regression model was used to compare CEA, CAS, and TCAR outcomes …

Objectives Transcarotid artery revascularization (TCAR) is currently reimbursed by the
Centers for Medicare and Medicaid Services for treatment of medically and anatomically …

Objectives Transcarotid arterial revascularization (TCAR) is associated with a lower risk of
stroke or death than transfemoral carotid artery stenting (TF-CAS). TCAR infers a lower risk …

Objective Transcarotid artery revascularization (TCAR) is a novel approach to carotid
intervention that uses a direct carotid cut-down approach coupled with cerebral blood flow …

Background Carotid artery stenting (CAS), including both transfemoral carotid artery stenting
(TFCAS) and transcarotid artery revascularization (TCAR), reimbursement has been limited …

Objective Transcarotid artery revascularization (TCAR) with flow reversal offers a less
invasive option for carotid revascularization in high-risk patients and has the lowest reported …